Cartilage repair faces a biological limitation: articular cartilage is largely avascular, so access to circulating repair resources is restricted, and it contains relatively few chondrocytes, the resident cells associated with cartilage maintenance. These features help explain why damage may persist and why treatments often add cells, graft tissue, or regenerative stimuli.
These approaches differ in what supplies the proposed repair response. Microfracture may stimulate marrow-derived cells, while grafting places replacement tissue in the damaged area. Cell-based strategies introduce cells, and biomaterial-based methods provide a supporting setting for new extracellular matrix formation. This distinction explains why cartilage repair includes both established clinical techniques and emerging regenerative designs.
New extracellular matrix formation is central because it provides the structural material associated with cartilage tissue. Strategies that support matrix production therefore seek more than short-term symptom relief: they aim for repair that is biologically integrated and durable. This focus connects cell delivery and biomaterials with the longer-term goal of restoring joint function.
Microfracture occupies a marrow-stimulation role among clinical cartilage-repair options. Its intended contribution is to stimulate marrow-derived cells rather than directly replace the damaged surface with a graft. That makes it mechanistically distinct from osteochondral grafting and from approaches centered on implanted chondrocytes or biomaterials. It is an example of biologic stimulation.
Clinical options span different repair concepts. Osteochondral grafting replaces damaged tissue with grafts, whereas autologous chondrocyte implantation centers on implanting chondrocytes. Emerging tissue-engineering methods may deliver cells together with biomaterials that support new extracellular matrix formation. Comparing these approaches shows how cartilage repair can replace tissue, add cells, or create a regenerative environment.
The clinical value of cartilage repair is assessed against several connected goals: reducing pain, improving joint function, and delaying osteoarthritis or joint replacement. These aims explain why the field includes both established procedures and emerging regenerative methods. A strategy is relevant not only for its biological mechanism but also for whether it supports meaningful joint function over time.